GlycoMimetics
Why Robinhood?
You can watch GlycoMimetics and buy or sell other stocks, ETFs, and their options commission-free!About GLYC
Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.
GLYC Key Statistics
Stock Snapshot
GlycoMimetics(GLYC) stock is priced at $13.04, giving the company a market capitalization of 181.16M. It carries a P/E multiple of -0.53.
On 2026-02-23, GlycoMimetics(GLYC) stock opened at —, reached a high of —, and a low of —.
GlycoMimetics(GLYC) shares are trading with a volume of 0, against a daily average of 242.08K.
In the last year, GlycoMimetics(GLYC) shares hit a 52-week high of $29.23 and a 52-week low of $8.72.
In the last year, GlycoMimetics(GLYC) shares hit a 52-week high of $29.23 and a 52-week low of $8.72.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.